Famiciclovir: Difference between revisions

Latest revision as of 19:45, 22 September 2019

Redirect to:

Authors:

@@ Line 1: / Line 1: @@
-==Administration==
+#REDIRECT[[Famciclovir]]
-*Type: [[Antiviral]]
-*Dosage Forms:
-*Routes of Administration: Oral
-*Common Trade Names: Famvir
-==Adult Dosing==
-*150-1000mg PO BID
-==Pediatric Dosing==
-''Safety/efficacy not established''
-==Special Populations==
-*[[Drug pregnancy categories|Pregnancy Rating]]: B
-*Lactation risk: Infant risk cannot be ruled out
-*Renal dosing: reduced dose
-*Hepatic dosing: no adjustment for mild-moderate impairment
-==Contraindications==
-*Allergy to class/drug
-==Adverse Reactions==
-===Serious===
-*Neutropenia
-*Elevated AST/ALT
-===Common===
-*Nausea/vomiting, diarrhea
-*Headache
-*Fatigue
-==Pharmacology==
-*Half-life: 2.3h
-*Metabolism: Hepatic
-*Excretion: Mostly renal
-==Mechanism of Action==
-*Inhibits viral DNA synthesis
-==Comments==
-==See Also==
-*[[Herpes simplex]]
-==References==
-<references/>
-[[Category:Pharmacology]]